KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Accumulated Expenses (2016 - 2025)

Quest Diagnostics' Accumulated Expenses history spans 14 years, with the latest figure at $338.0 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 10.46% year-over-year to $338.0 million; the TTM value through Dec 2025 reached $338.0 million, up 10.46%, while the annual FY2025 figure was $338.0 million, 10.46% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $338.0 million at Quest Diagnostics, up from $306.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $460.0 million in Q4 2021 and bottomed at $287.0 million in Q4 2023.
  • The 5-year median for Accumulated Expenses is $338.0 million (2025), against an average of $356.6 million.
  • The largest annual shift saw Accumulated Expenses rose 29.21% in 2021 before it dropped 26.79% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $460.0 million in 2021, then dropped by 14.78% to $392.0 million in 2022, then dropped by 26.79% to $287.0 million in 2023, then increased by 6.62% to $306.0 million in 2024, then increased by 10.46% to $338.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Accumulated Expenses are $338.0 million (Q4 2025), $306.0 million (Q4 2024), and $287.0 million (Q4 2023).